Catch up on the latest news and updates from the Barts Cancer Institute, Queen Mary University of London. From important announcements to behind-the-scenes highlights, there’s always something new to explore. Scroll down to read the latest posts and see what we've been up to.
Barts Cancer Institute, Queen Mary University of London will co-lead a ground-breaking collaboration, PharosAI, that aims to harness cutting-edge artificial intelligence (AI) and unlock decades of NHS cancer data. The UK government is committing £18.9 million to the project.
General News 11 February 2025
Barts Cancer Institute, Queen Mary Univerity of London, is delighted to announce the publication of a special commemorative book celebrating twenty years of cancer discoveries since the establishment of the institute.
General News 4 February 2025
Professor Louise Jones has been awarded the Pathological Society’s prestigious Goudie Medal for her seminal contributions to pathological science and understanding of disease.
General News 22 January 2025
Researchers have shown that the amount of a protein called CD74 can indicate which people with bowel cancer may respond best to immunotherapy.
General News 16 January 2025
Dr Michael Spencer Chapman and team have uncovered forms of DNA damage in healthy cells that can persist unrepaired for years
General News 15 January 2025
A genetic fault long believed to drive the development of oesophageal cancer may in fact play a protective role early in the disease, according to new research published in Nature Cancer.
General News 3 January 2025
Join us as we look back at some highlights of Barts Cancer Institute’s news stories this year.
General News 20 December 2024
We explore Nobel-Prize-winning research and the theory behind AI, and speak with Dr Vivek Singh, Dr Oscar Maiques and Professor Claude Chelala, three researchers using cutting-edge AI in their work at the BCI.
General News 16 December 2024
New research sheds light on how certain non-cancerous cells in pancreatic cancer can affect the body’s natural immune defences and could have a significant impact on patients’ survival.
General News 12 December 2024
Congratulations to Professor Sarah McClelland, who has received a £1,500,000 Programme Foundation Award from Cancer Research UK (CRUK), to support her lab’s work at Barts Cancer Institute (BCI), Queen Mary University of London.
General News 25 November 2024
An innovative cancer-killing virus shows promise for tackling glioblastoma, an aggressive type of brain tumour, according to new results from a phase I clinical trial co-led by researchers at Barts Cancer Institute.
General News 8 November 2024
Researchers at the BCI and the Crick have been awarded a €9.8m ERC Synergy grant for their pioneering 6-year project called MUTAHOME.
General News 5 November 2024
The BCI is advancing radiation research through the Cancer Reserach UK City of London Radiation Research Centre of Excellence, an £18M partnership with the Crick, UCL and King's.
General News 30 October 2024
New research reveals that the most common type of oesophageal cancer, oesophageal squamous cell carcinoma (ESCC), is composed of four distinct subtypes—each of which may benefit from different treatment approaches.
General News 23 October 2024
Researchers at Barts Cancer Institute reveal promising acute myeloid leukaemia treatment targeting fat metabolism, addressing the urgent need for better therapies.
General News 17 October 2024
We recently welcomed a group of 16 cancer patient advocates into our labs for the 11th edition of our VOICE science for advocates course, co-run with the charity Independent Cancer Patients' Voice.
Engagement 10 October 2024
Researchers from Barts Cancer Institute, Queen Mary University of London are part of a nationwide team of universities, hospitals and industry collaborating on a new platform to understand immunotherapy response and side effects in cancer.
General News 7 October 2024
For Blood Cancer Awareness Month, Dr Lou Herman reflects on the current challenges facing blood cancer patients and how we’re addressing them.
Interviews 30 September 2024